For the first time since the outbreak of the disease, Ebola, the World Health Organization (WHO) has prequalified a vaccine and accelerated its licensing, access and roll-out in countries at the peril of the disease.
The new vaccine is called ‘Ervebo’. It is the fastest vaccine prequalification process carried out by WHO as it ranks top in quality, safety and efficacy.
Ervebo was invented by Merck (known as MSD outside the US and Canada). It has been proven to have a potency to prevent people from the Ebola Zaire virus. WHO’s Strategic Advisory Group of Experts (SAGE) put forward the vaccine as part of the broader set of Ebola response tools.
“This is a historic step towards ensuring the people who most need it are able to access this life-saving vaccine,” said Dr. Tedros Adhanom Ghebreyesus, Director-General of WHO.
“Five years ago, we had no vaccine and no therapeutics for Ebola. With a prequalified vaccine and experimental therapeutics, Ebola is now preventable and treatable.”
WHO further announced that licensed doses will be made available mid-2020